EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver

Seunghee Kim iD, Yeojin Kim iD, Sanjita Paudel iD, In Young Kang iD, Suyeon Kim iD, Jeesoo Kim iD, Sunmi Park, Seung-Hoi Koo iD, Hyun Sung Kim, Dae Won Jun iD, Jinyoung Park iD, Hyunbeom Lee iD und 1 weitere

Advanced Materials · 2026

DOI: 10.1002/adma.202506373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Seunghee Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Hanyang University, Seoul, 04763, Republic of Korea. Hauptthemen laut MEDLINE: Lipid Droplets, Liver, Fatty Liver, Lipid Metabolism. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Institute of Science and Technology, Ministry of Food and Drug Safety, Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive lipid droplet accumulation in hepatocytes drives the progression of metabolic dysfunction‐associated steatotic liver disease (MASLD), often leading to inflammation and fibrosis. As obesity and metabolic syndrome rise, MASLD has become a global concern, spurring research into effective treatments. Here, the design of a Lipid droplet inhibitor (LDI) is presented, incorporating porous silica nanostructures along with PKCα C1A and Candida Rugosa lipase, aimed at directly degrading lipid droplets. Through its dual‐functional design, this nanostructure captures diacylglycerol using PKCα C1A while hydrolyzing triacylglycerol into smaller molecular fragments via the lipase. Notably, the amphiphilic biomolecules in LDI facilitate the formation of a Pickering emulsion, ensuring stable localization at the lipid‐water interface for efficient interaction with lipid droplets. LDI reduces lipid droplet formation and triglyceride levels in palmitic acid‐treated HepG2 cells. In a high‐fat diet‐induced MASLD model, it alleviateds liver pathology and, lowered injury scores by up to 84%. Furthermore, lipidomic analysis confirmed that LDI effectively modulated the hepatic lipid profile, suggesting its potential as a nanoplatform for counteracting lipid droplet accumulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid DropletsLiverFatty LiverLipid MetabolismHumansAnimalsHep G2 CellsMiceMaleLipaseTriglyceridesMice, Inbred C57BLNanostructuresSilicon DioxideDiet, High-Fat

Stichwörter der Autor:innen

dual‐function nanostructureinterfacial biocatalysislipid droplet degradationmetabolic dysfunction–associated liver disease (MASLD)pickering emulsion

Substanzen

LipaseTriglyceridesSilicon Dioxide

Autor:innen und Institutionen

  • Department of Chemistry, Hanyang University, Seoul, 04763, Republic of Korea.
  • Research Institute for Convergence of Basic Sciences, Hanyang University, Seoul, 04763, Republic of Korea.
  • VN Inc., Seoul, 04763, Republic of Korea.
  • Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
  • Division of Life Sciences, College of Life Sciences and Biotechnology, Korea University, Seoul, 02841, Republic of Korea.
  • Department of Translational Medicine, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, 04763, South Korea.

ORCID-Profile: Seunghee Kim, Yeojin Kim, Sanjita Paudel, In Young Kang, Suyeon Kim, Jeesoo Kim, Seung-Hoi Koo, Dae Won Jun, Jinyoung Park, Hyunbeom Lee, Joonseok Lee

Förderung

  • Korea Institute of Science and Technology
  • Ministry of Food and Drug Safety
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Kim, S., Kim, Y., Paudel, S., Kang, I. Y., Kim, S., Kim, J., Park, S., Koo, S. H., Kim, H. S., Jun, D. W., Park, J., Lee, H., & Lee, J. (2026). LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver. Advanced Materials. https://doi.org/10.1002/adma.202506373

Vancouver

Kim S, Kim Y, Paudel S, Kang IY, Kim S, Kim J, et al. LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver. Advanced Materials. 2026. doi:10.1002/adma.202506373

BibTeX
@article{Kim2026,
  author = {Kim, Seunghee and Kim, Yeojin and Paudel, Sanjita and Kang, In Young and Kim, Suyeon and Kim, Jeesoo and Park, Sunmi and Koo, Seung-Hoi and Kim, Hyun Sung and Jun, Dae Won and Park, Jinyoung and Lee, Hyunbeom and Lee, Joonseok},
  title = {LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.202506373}
}
Kostenlos starten →